Last week, the administration announced that it would not finalize the demonstration project designed to test payment changes to drugs in Medicare Part B. Part B covers outpatient drugs, those that are administered in a doctor’s office or a hospital.
Read More...
Read the complete post at http://healthaffairs.org/blog/2016/12/27/the-demise-of-the-part-b-demo-doom-for-value-based-payment/
Posted
Dec 27 2016, 09:00 AM
by
Health Affairs BlogHealth Affairs Blog